BRUSSELS, Nov 2 (IPS) - Médecins Sans Frontières and other groups campaigning for access to affordable medicines in developing countries are closely following a case filed by the Swiss pharmaceuticals giant Novartis against Indian patent law.
A decision in this case can create an important precedent, with consequences that go far beyond India. "If the Novartis challenge against the Indian patent law is successful, patients worldwide who depend on India for affordable medicines risk becoming victims," Ellen 't Hoen, policy director with the Médecins Sans Frontières (MSF) Campaign for Access to Essential Medicines told IPS.
Nov 5, 2006
Affordable medicine? Novartis says no...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment